CN102016587B - 新的转移性人类肿瘤相关分子、检测激活的基因和蛋白的方法以及干扰基因表达的方法 - Google Patents

新的转移性人类肿瘤相关分子、检测激活的基因和蛋白的方法以及干扰基因表达的方法 Download PDF

Info

Publication number
CN102016587B
CN102016587B CN200980111385.6A CN200980111385A CN102016587B CN 102016587 B CN102016587 B CN 102016587B CN 200980111385 A CN200980111385 A CN 200980111385A CN 102016587 B CN102016587 B CN 102016587B
Authority
CN
China
Prior art keywords
tucap
cells
protein
seq
melanoma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN200980111385.6A
Other languages
English (en)
Chinese (zh)
Other versions
CN102016587A (zh
Inventor
F·洛祖波内
S·法伊斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Waisomix Co ltd
Original Assignee
Hansabiomed OU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hansabiomed OU filed Critical Hansabiomed OU
Publication of CN102016587A publication Critical patent/CN102016587A/zh
Application granted granted Critical
Publication of CN102016587B publication Critical patent/CN102016587B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CN200980111385.6A 2008-01-25 2009-01-26 新的转移性人类肿瘤相关分子、检测激活的基因和蛋白的方法以及干扰基因表达的方法 Expired - Fee Related CN102016587B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6245308P 2008-01-25 2008-01-25
US61/062453 2008-01-25
PCT/EE2009/000001 WO2009092385A1 (en) 2008-01-25 2009-01-26 A new metastatic human tumor associated molecule, methods to detect both activated gene and protein and to interfere with gene expression

Publications (2)

Publication Number Publication Date
CN102016587A CN102016587A (zh) 2011-04-13
CN102016587B true CN102016587B (zh) 2015-05-13

Family

ID=40527972

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200980111385.6A Expired - Fee Related CN102016587B (zh) 2008-01-25 2009-01-26 新的转移性人类肿瘤相关分子、检测激活的基因和蛋白的方法以及干扰基因表达的方法

Country Status (12)

Country Link
US (1) US8097407B2 (https=)
EP (1) EP2245465B1 (https=)
JP (1) JP5752419B2 (https=)
CN (1) CN102016587B (https=)
AU (1) AU2009207926B2 (https=)
BR (1) BRPI0906681A2 (https=)
CA (1) CA2713193C (https=)
ES (1) ES2587055T3 (https=)
MX (1) MX2010008163A (https=)
PL (1) PL2245465T3 (https=)
RU (1) RU2546000C2 (https=)
WO (1) WO2009092385A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120122118A1 (en) * 2008-01-25 2012-05-17 Primm Srl Monclonal antibodies, hybridomas and methods for use
EP2467392A4 (en) * 2009-08-17 2013-06-19 Nox Technologies Inc CLONING AND EXPRESSION OF 9-DOMAIN SUPERFAMILY OF ARNOX TRANSMEMBRANE PROTEINS, METHODS AND UTILITY
JP6187939B2 (ja) * 2012-03-08 2017-08-30 学校法人産業医科大学 がんの悪性度の試験方法、ならびに多能性を有する造腫瘍細胞およびその調製方法
WO2015185730A2 (en) * 2014-06-06 2015-12-10 Hansabiomed Ou Exosomal biomarkers
CN105675378A (zh) * 2014-11-18 2016-06-15 上海张江转化医学研发中心有限公司 一种简单的分离单个循环肿瘤细胞的方法和装置
JP6573351B2 (ja) 2017-05-29 2019-09-11 国立大学法人神戸大学 検出対象の分析用センサ作製用基材、検出対象の分析用センサ、及び検出対象の分析法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030008356A1 (en) * 1998-08-07 2003-01-09 Ono Pharmaceutical Co., Ltd. Novel polypeptide, a cDNA encoding the same, and use of it
WO2006110593A2 (en) * 2005-04-07 2006-10-19 Macrogenics, Inc. Biological targets for the diagnosis, treatment and prevention of cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030175787A1 (en) * 1997-10-28 2003-09-18 Incyte Corporation Vesicle membrane proteins
WO2000008056A1 (fr) * 1998-08-07 2000-02-17 Ono Pharmaceutical Co., Ltd. NOUVEAU POLYPEPTIDE, ADNc LE CODANT ET SON UTILISATION
US20070224201A1 (en) * 2002-10-02 2007-09-27 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
WO2005108415A2 (en) * 2004-04-30 2005-11-17 Biogen Idec Ma Inc. Membrane associated molecules

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030008356A1 (en) * 1998-08-07 2003-01-09 Ono Pharmaceutical Co., Ltd. Novel polypeptide, a cDNA encoding the same, and use of it
WO2006110593A2 (en) * 2005-04-07 2006-10-19 Macrogenics, Inc. Biological targets for the diagnosis, treatment and prevention of cancer

Also Published As

Publication number Publication date
EP2245465A1 (en) 2010-11-03
AU2009207926B2 (en) 2014-06-19
PL2245465T3 (pl) 2016-11-30
US20090191222A1 (en) 2009-07-30
RU2546000C2 (ru) 2015-04-10
EP2245465B1 (en) 2016-05-18
MX2010008163A (es) 2011-04-26
JP5752419B2 (ja) 2015-07-22
ES2587055T3 (es) 2016-10-20
JP2011511625A (ja) 2011-04-14
US8097407B2 (en) 2012-01-17
CA2713193A1 (en) 2009-07-30
RU2010135525A (ru) 2012-02-27
BRPI0906681A2 (pt) 2019-11-26
WO2009092385A1 (en) 2009-07-30
CA2713193C (en) 2018-01-02
CN102016587A (zh) 2011-04-13
AU2009207926A1 (en) 2009-07-30

Similar Documents

Publication Publication Date Title
US7998689B2 (en) Detection of CXADR protein for diagnosis of kidney cancer
US7521195B1 (en) Lung disease targets and uses thereof
US8524238B2 (en) Cancer targets and uses thereof
US7358231B1 (en) Pancreatic cancer secreted targets and uses thereof
US7582441B1 (en) Methods and compositions for treating and diagnosing disease
CN102016587B (zh) 新的转移性人类肿瘤相关分子、检测激活的基因和蛋白的方法以及干扰基因表达的方法
US20090196873A1 (en) Methods and compositions for treating diseases targeting CDCP1
US20200291129A1 (en) Methods and compositions for diagnosing and treating diseases
CN103429617B (zh) 包含抗-ck8/18复合物自身抗体的标记物及其诊断癌症的用途
US20100172908A1 (en) Methods and compositions for treating diseases targeting maba1
US20120122118A1 (en) Monclonal antibodies, hybridomas and methods for use
US8507213B1 (en) Methods and compositions for treating diseases targeting maba
WO2006022682A2 (en) Method and compositions for treating diseases targeting cd49b
US7928188B2 (en) Antigen polypeptide for the diagnosis and/or treatment of ovarian cancer
TWI392504B (zh) 用於診斷及／或治療卵巢癌之抗原多肽
JPWO2006082851A1 (ja) エピグリカニン関連ムチン
US20100286243A1 (en) Mig-7 as a specific anticancer target

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20170331

Address after: Italy Siena

Patentee after: Transomex Siena

Address before: Tallinn

Patentee before: HANSABIOMED Ou

CP01 Change in the name or title of a patent holder
CP01 Change in the name or title of a patent holder

Address after: Italy Siena

Patentee after: Waisomix Co.,Ltd.

Address before: Italy Siena

Patentee before: Transomex Siena

CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20150513